Cell and Gene Logistics
-
Improving Access And Support For Cell And Gene Therapies
10/9/2023
Although cell and gene therapies (CGTs) are potentially transformative, their effectiveness is undermined by difficulties with patient access and support, high costs, and a complex pathway to treatment.
-
Future Challenges And Predictions For CGT Patient-Focused Solutions
10/4/2023
Leveraging innovative technologies to predict, model, and analyze data will enhance resource allocation, improve patient experience, reduce timelines, and drive cost efficiencies in the CGT industry.
-
FDA Announces 1-Year “Stabilization” Period For DSCSA Compliance — Don’t Mistake It For An Enforcement Delay
10/4/2023
On August 30 in a new guidance document, the FDA announced the establishment of a one-year stabilization period with regard to the enhanced security and unit-level electronic traceability requirements of the Drug Supply Chain Security Act (DSCSA) that go into effect on Nov. 27, 2023. The FDA makes it clear that this is not an opportunity to delay implementation; rather, it is an opportunity to refine, improve, and stabilize your systems and processes.
-
3 Questions To Ask When Building A CGT Commercialization Strategy
10/3/2023
Learn how aligning with the right partner and leveraging integrated solutions gives access to crucial know-how and ensures the patient receives the most seamless, accessible treatment option available.
-
CGT Solutions Brochure
9/30/2023
Leveraging a partner with expertise and integrated, end-to-end solutions can help overcome obstacles to increase patient access and ensure the safe distribution of your advanced therapy product.
-
Cell & Gene Therapy Solutions
9/29/2023
Your therapy can make all the difference. Together, we’ll unlock its potential.
-
How Innovations In Cryologistics Support Patient Access To CGTs
9/28/2023
Understanding the infrastructure required to fulfill the CGT demands and finding the right partner to meet these demands are crucial components for delivering quality products and expanding CGT access.
-
Film Types For Corning® Single-Use Containers
9/27/2023
These single-use containers provide a high quality and cost effective solution, utilize films that have undergone a range of biocompatibility tests, and can be customized to match your needs.
-
Custom Masterflex Single-Use Bioprocess Assemblies
9/21/2023
Customized for your needs
Trusted configurations that meet the highest quality in assembly and sterilization.
What was once a multistep process of ordering, assembling, sterilizing and validating now requires just one call to us. As a respected supplier of nearly every component in the bio disposables market, we offer the widest selection of brands for truly custom fluid handling solutions.
-
Primary Pharmaceutical Glass Packaging
9/19/2023
We’ve applied our expertise in glass science, optical physics, vapor deposition, precision forming, and extrusion to design and develop a 21st century glass container to protect 21st century drugs and vaccines. Corning® Valor® Glass vials enhance the storage and delivery of drugs, providing more reliable access to medicines essential to public health.